Curis (CRIS) Retained Earnings (2010 - 2026)
Curis (CRIS) reported Retained Earnings of -$1.3 billion for Q1 2026, down 1.69% on a YoY basis from -$1.3 billion in Q1 2025, and down 1.94% quarter-over-quarter from -$1.2 billion in Q4 2025.
Curis (CRIS) Retained Earnings (2010 - 2026) Analysis & Trends
Curis has reported Retained Earnings for 17 years, with the latest figure at -$1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 1.69% year-over-year to -$1.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.3 billion (down 1.69% YoY), and the FY2025 full-year result was -$1.2 billion, down 0.61% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.3 billion, down from -$1.2 billion in the prior quarter.
- The five-year high for Retained Earnings was $338000.0 in Q1 2024, with the low at -$1.3 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$932.5 million across 5 years, with a median of -$1.2 billion in 2023.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 12222122.22% — and 2024, when it surged 100.03%.
- Curis' Retained Earnings stood at -$186000.0 in 2022, then tumbled by 643131.18% to -$1.2 billion in 2023, then retreated by 3.63% to -$1.2 billion in 2024, then retreated by 0.61% to -$1.2 billion in 2025, then dropped by 1.94% to -$1.3 billion in 2026.
- The last three Retained Earnings figures came in at -$1.3 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -1.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.27 Bn |
| Dec 31, 2025 | -1.25 Bn |
| Sep 30, 2025 | -1.30 Bn |
| Jun 30, 2025 | -1.26 Bn |
| Mar 31, 2025 | -1.25 Bn |
| Dec 31, 2024 | -1.24 Bn |
| Sep 30, 2024 | -1.23 Bn |
| Jun 30, 2024 | -1.22 Bn |
| Mar 31, 2024 | 338,000.00 |
| Dec 31, 2023 | -1.20 Bn |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | -1.20 Bn |
| Mar 31, 2023 | -1.20 Bn |
| Dec 31, 2022 | -186,000.00 |
| Sep 30, 2022 | -1.14 Bn |
| Jun 30, 2022 | -555,000.00 |
| Mar 31, 2022 | -1.10 Bn |
| Dec 31, 2021 | -109,000.00 |
| Sep 30, 2021 | -1.10 Bn |
| Jun 30, 2021 | -1.10 Bn |